Diabetes Risk Prediction Models and Assessment Tools

The global burden of type 2 diabetes continues to rise, driving the need for accurate prediction models and assessment tools to identify at‐risk individuals and guide prevention strategies. Early efforts focused on non‐invasive scores using demographic and anthropometric measures such as age, body mass index and waist circumference. Subsequently, regression‐based algorithms incorporated clinical biomarkers including fasting plasma glucose, glycated haemoglobin and lipid profiles to enhance performance. More recently, machine learning techniques—ranging from decision trees and support vector machines to ensemble methods—have been introduced to capture complex non‐linear relationships among predictors. Contemporary models emphasise calibration, discrimination and external validity in diverse populations, with ongoing work to address algorithmic bias and ensure equity. Integration of electronic health records, wearable‐device data and emerging omics markers offers further opportunities for dynamic, personalised risk assessment. Despite promising advances, challenges remain in translating high‐dimensional algorithms into routine clinical practice, harmonising predictor definitions and embedding tools within digital health platforms for real‐time risk monitoring.

Research from Nature Portfolio

Recent studies have demonstrated that ensemble machine learning algorithms can outperform traditional regression in large healthcare datasets. A gradient boosting decision tree model applied to over 270 000 health check records achieved superior calibration and discrimination compared with logistic regression, particularly as sample sizes increased beyond ten thousand. This approach improved reliability of predicted probabilities for three‐year diabetes incidence, underscoring the potential of advanced machine learning to deliver robust, scalable risk prediction in population‐level screening and prevention programmes.

Diabetes Risk Prediction Models and Assessment Tools publication trend

The graph below shows the total number of articles in diabetes risk prediction models and assessment tools across all publications each year (not limited to Nature Index journals).

Technical terms

Gradient boosting decision tree (GBDT): An ensemble machine learning method that builds decision trees sequentially to minimise prediction error.

Calibration: The agreement between predicted risks and observed outcomes across risk strata.

Discrimination: The ability of a model to distinguish between individuals who develop diabetes and those who do not, often measured by the area under the receiver operating characteristic curve.

Cox proportional hazards model: A statistical regression technique for time‐to‐event data that estimates the hazard of developing an event, adjusting for competing risks.

Nomogram: A graphical tool that translates a multivariable predictive model into a numerical estimate of individual risk.

References

1. Machine learning in precision diabetes care and cardiovascular risk prediction. Cardiovascular Diabetology (2023).
2. Development and validation of a lifetime prediction model for incident type 2 diabetes in patients with established cardiovascular disease: the CVD2DM model. European Journal of Preventive Cardiology (2024).
3. Gradient boosting decision tree becomes more reliable than logistic regression in predicting probability for diabetes with big data. Scientific Reports (2022).